Bergapten
- Generic Name
- Bergapten
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C12H8O4
- CAS Number
- 484-20-8
- Unique Ingredient Identifier
- 4FVK84C92X
- Background
Bergapten is under investigation in clinical trial NCT00533195 (Comparison of UVA1 Phototherapy Versus Photochemotherapy for Patients With Severe Generalized Atopic Dermatitis).
- Associated Conditions
- -
- Associated Therapies
- -
Comparison of UVA1 Phototherapy Versus Photochemotherapy for Patients With Severe Generalized Atopic Dermatitis
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-09-21
- Last Posted Date
- 2009-01-14
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 20
- Registration Number
- NCT00533195
- Locations
- π¦πΉ
Medical University of Vienna; University Clinic of Dermatology; Division of Special and Environmental Dermatology, Vienna, Austria
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
Β© Copyright 2024. All Rights Reserved by MedPath